Latest 10-K annual reports

Ovid Therapeutics files an amendment to its annual report to include information required by Items 10 through 14 of Part III, related to directors, executive officers, compensation, and corporate governance.

Rocket Lab has filed an amendment to its 2024 Annual Report on Form 10-K to include information regarding directors, executive officers, corporate governance, and executive compensation.

Tempest Therapeutics files an amendment to its annual report on Form 10-K to include required information on directors, executive officers, corporate governance, and updated certifications.

LENSAR, Inc. files an amendment to its annual report on Form 10-K to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and principal accountant fees.

SES AI Corporation filed an amendment to its 2024 annual report to include information on directors, executive officers, and their compensation.

Plus Therapeutics files an amendment to its 2024 Annual Report on Form 10-K to include information previously omitted from Part III, Items 10 through 14, and updates the exhibit list and share outstanding information.

Volato Group, Inc. files an amendment to its 2024 Annual Report on Form 10-K to include information required by Part III, which was previously omitted.

BankFinancial Corporation files an amendment to its 2024 annual report on Form 10-K to include information required in Part III, focusing on directors, executive officers, and corporate governance.

Volcon, Inc. files an amendment to its 2024 annual report to include certain interactive data file tagging and certifications by the principal executive and financial officers.

Expion360 Inc. files an amendment to its 2024 Annual Report on Form 10-K/A to include Part III information regarding directors, executive officers, and corporate governance.

Scorpius Holdings grapples with NYSE American delisting, significant losses, and a search for strategic options as it navigates a challenging financial landscape.

UroGen Pharma files an amendment to its 2024 annual report to include information required by Part III of Form 10-K, covering directors, executive officers, compensation, security ownership, related transactions, and accountant fees.

i-80 Gold Corp. files an amendment to its 2024 annual report to include Part III information regarding directors, executive officers, and corporate governance.

Four Leaf Acquisition Corporation's annual report reveals a company grappling with financial uncertainties, Nasdaq delisting notices, and ongoing efforts to finalize a business combination with Xiaoyu Dida.

American Rebel Holdings files an amendment to its 2024 Annual Report on Form 10-K to include an inadvertently omitted exhibit regarding executive compensation recovery policy.

BGC Group files an amendment to its 2024 annual report, providing additional information on directors, executive compensation, corporate governance, and related matters.

KAT Exploration, Inc.'s 10-K filing reveals a net loss, limited operations focused on seeking a business combination, and a recent joint venture in gold mining.

Medicus Pharma Ltd. files an amendment to its annual report on Form 10-K to include information required by Part III, covering directors, executive officers, corporate governance, and executive compensation.

Sotherly Hotels Inc. and Sotherly Hotels LP file an amendment to their Annual Report on Form 10-K for the fiscal year ended December 31, 2024, to include information required by Part III regarding directors, executive officers, and corporate governance.

IIOT-OXYS, Inc.'s 10-K filing reveals a decrease in revenue, a net loss, and substantial doubt about the company's ability to continue as a going concern due to limited funding and operational headwinds.

The Cannabist Company Holdings Inc. amends its annual report on Form 10-K to correct a typographical error in the auditor's report and include a performance graph.

XBP Europe Holdings files an amendment to its 2024 Annual Report to include previously omitted information regarding directors, executive compensation, ownership, related transactions, accountant fees, and to introduce an executive severance plan.

Newmark Group amends its 2024 Annual Report on Form 10-K to include previously omitted information regarding directors, executive officers, corporate governance, and executive compensation.

Synlogic files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, security ownership, related transactions, and accounting fees.

Nutex Health files an amendment to its annual report to include previously omitted information regarding directors, executive officers, corporate governance, executive compensation, security ownership, related person transactions, and principal accountant fees.

Old Point Financial Corporation files an amendment to its 2024 annual report on Form 10-K to include previously omitted information regarding directors, executive officers, and corporate governance, as well as an updated exhibit index, ahead of its merger with TowneBank.

Powerdyne International, Inc. reports a decrease in revenue and an increased net loss for the year ended December 31, 2024, compared to the previous year, while addressing going concern uncertainties.

22nd Century Group files an amendment to its 2024 annual report to include previously omitted information regarding directors, executive compensation, and corporate governance.

Pulse Biosciences files an amendment to its 2024 Annual Report on Form 10-K to include information previously omitted regarding directors, executive officers, compensation, and corporate governance.

WidePoint Corporation files an amendment to its annual report on Form 10-K to include previously omitted information from Part III, Items 10-14.